Related Experiment Video
Updated: Oct 20, 2025

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
Follistatin-Like-1 (FSTL1) Is a Fibroblast-Derived Growth Factor That Contributes to Progression of Chronic Kidney
Nicholas A Maksimowski1, Xuewen Song2, Eun Hui Bae3
1Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada.
Abstract:
Our understanding of the mechanisms responsible for the progression of chronic kidney disease (CKD) is incomplete. Microarray analysis of kidneys at 4 and 7 weeks of age in Col4a3 mice, a model of progressive nephropathy characterized by proteinuria, interstitial fibrosis, and inflammation, revealed that Follistatin-like-1 (Fstl1) was one of only four genes significantly overexpressed at 4 weeks of age. mRNA levels for the Fstl1 receptors, Tlr4 and Dip2a, increased in both Col4a mice and mice subjected to unilateral ureteral obstruction (UUO). RNAscope® (Advanced Cell Diagnostics, Newark CA, USA) localized Fstl1 to interstitial cells, and in silico analysis of single cell transcriptomic data from human kidneys showed Fstl1 confined to interstitial fibroblasts/myofibroblasts. In vitro, FSTL1 activated AP1 and NFκB, increased collagen I (COL1A1) and interleukin-6 (IL6) expression, and induced apoptosis in cultured kidney cells. FSTL1 expression in the NEPTUNE cohort of humans with focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN), and IgA nephropathy (IgAN) was positively associated with age, eGFR, and proteinuria by multiple linear regression, as well as with interstitial fibrosis and tubular atrophy. Clinical disease progression, defined as dialysis or a 40 percent reduction in eGFR, was greater in patients with high baseline FSTL1 mRNA levels. FSTL1 is a fibroblast-derived cytokine linked to the progression of experimental and clinical CKD.
Insights
Follistatin-like-1 (FSTL1) is a key factor in chronic kidney disease (CKD) progression. This study links FSTL1 to kidney damage and disease advancement in both mouse models and human patients.
Area of Science:
- Nephrology
- Molecular Biology
- Genetics
Background:
- Chronic kidney disease (CKD) progression mechanisms remain incompletely understood.
- Follistatin-like-1 (FSTL1) was identified as a significantly overexpressed gene in a mouse model of progressive nephropathy.
- FSTL1 receptors (Tlr4, Dip2a) were upregulated in kidney injury models.
Purpose of the Study:
- To investigate the role of Follistatin-like-1 (FSTL1) in the progression of chronic kidney disease (CKD).
- To determine the cellular localization and functional impact of FSTL1 in kidney cells.
- To assess the association of FSTL1 with clinical parameters and disease progression in human kidney diseases.
Main Methods:
- Microarray analysis in *Col4a3* mice and unilateral ureteral obstruction (UUO) models.
- RNAscope in situ hybridization and in silico analysis of human kidney single-cell transcriptomics.
- In vitro studies using cultured kidney cells to assess FSTL1 signaling pathways and gene expression.
- Analysis of the NEPTUNE cohort for correlations between FSTL1 levels and clinical outcomes in FSGS, MN, and IgAN.
Main Results:
- FSTL1 was significantly overexpressed early in a mouse model of progressive kidney disease.
- FSTL1 was localized to interstitial fibroblasts/myofibroblasts in mouse and human kidneys.
- In vitro, FSTL1 activated AP1 and NFκB, increased collagen and IL6 expression, and induced apoptosis.
- In human patients, FSTL1 expression correlated with age, eGFR, proteinuria, and interstitial fibrosis.
- High baseline FSTL1 levels were associated with greater clinical CKD progression.
Conclusions:
- Follistatin-like-1 (FSTL1) is a fibroblast-derived cytokine implicated in experimental and clinical CKD progression.
- FSTL1 signaling pathways contribute to kidney fibrosis and inflammation.
- FSTL1 serves as a potential biomarker and therapeutic target for managing CKD progression.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Introduction to Fibroblasts
Acute Kidney Injury II: Pathophysiology
Nephrons

